, Tracking Stock Market Picks
Enter Symbol:
Incyte Corporation (INCY) [hlAlert]

up 69.26 %

Incyte Corporation (INCY) rated Buy with price target $84 by BofA/Merrill

Posted on: Wednesday,  Feb 26, 2014  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Incyte Corporation (NASDAQ: INCY) on 02/26/2014, when the stock price was $67.26. Since
then, Incyte Corporation has gained 69.27% as of 01/14/2016's recent price of $113.85.
If you would have followed this BofA/Merrill's recommendation on INCY, you would have gained 69.26% of your investment in 687 days.

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte?s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2014 8:25 AM Buy
67.26 84.00
as of 10/17/2014
1 Week up  8.63 %
1 Month up  3.77 %
3 Months up  10.42 %
1 YTD down  -25.54 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy